As of May 05, 2025, Fulcrum Therapeutics (FULC) has a market cap of $0.20 billion USD. According to our data, Fulcrum Therapeutics is ranked No.7039 in global market value.
Year | Market Cap | %Change |
---|---|---|
May 05, 2025 | $0.20 B |
-22.28%
|
Dec 31, 2024 | $0.25 B |
-30.37%
|
Dec 29, 2023 | $0.36 B |
-7.28%
|
Dec 30, 2022 | $0.39 B |
-58.85%
|
Dec 31, 2021 | $0.95 B |
51.07%
|
Dec 31, 2020 | $0.63 B |
-29.63%
|
Dec 31, 2019 | $0.90 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Sarepta Therapeutics
SRPT
|
$5.98 B |
0.000 M
|
![]() USA
|
![]() Avidity Biosciences
RNA
|
$3.87 B |
-0.000 M
|
![]() USA
|
![]() Wave Life Sciences
WVE
|
$1.13 B |
0.000 M
|
![]() Singapore
|
![]() Solid Biosciences
SLDB
|
$0.24 B |
-0.000 M
|
![]() USA
|
![]() BioMarin Pharmaceutical
BMRN
|
$12.13 B |
0.000 M
|
![]() USA
|
![]() PTC Therapeutics
PTCT
|
$3.91 B |
0.000 M
|
![]() USA
|
![]() Ultragenyx
RARE
|
$3.57 B |
0.000 M
|
![]() USA
|
![]() Ionis Pharmaceuticals
IONS
|
$4.74 B |
0.000 M
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$127.64 B |
0.004 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.16 B |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.23 B |
-0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$40.34 M |
0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.85 B |
-0.000 M
|
![]() USA
|
Market Cap | = | FULC Stock Price | * | FULC Shares Outstanding |
= | $3.65 | * | 53.98 M | |
= | $0.20 B |